Scientific publication confirming the efficacy of Pill Protect®, an innovative genetic test to assess the risk of thrombosis in women using contraceptive pill

Gene Predictis®, in collaboration with the group of Prof. Zoltàn Kutalik at CHUV (University Hospital of Canton Vaud) and the SIB Swiss Institute of Bioinformatics, published a study concerning Pill Protect® test, an innovative medical test that uses genetic data to identify women at risk of developing thrombosis when using contraceptive pills. This study identified two new genetic markers associated with the development of thrombosis as well as a combination of specific clinical and genetic factors to measure the risk of thrombosis in women using combined oral contraceptives. Pill Protect® is already available in Switzerland and reimbusrsed, it helps to identify women at risk more effectively and precisely than ever before.